{"id":"https://openalex.org/W3014222695","doi":"https://doi.org/10.1016/j.vaccine.2020.02.081","title":"Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina","display_name":"Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3014222695","doi":"https://doi.org/10.1016/j.vaccine.2020.02.081","mag":"3014222695","pmid":"https://pubmed.ncbi.nlm.nih.gov/32249017"},"language":"en","primary_location":{"id":"doi:10.1016/j.vaccine.2020.02.081","doi":"https://doi.org/10.1016/j.vaccine.2020.02.081","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2020.02.081","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X2030325X/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0264410X2030325X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100638743","display_name":"Van Hung Nguyen","orcid":"https://orcid.org/0000-0002-8240-3641","observed_orcids":["https://orcid.org/0000-0002-8240-3641"]},"institutions":[{"id":"https://openalex.org/I60158472","display_name":"Concordia University","ror":"https://ror.org/0420zvk78","country_code":"CA","type":"education","lineage":["https://openalex.org/I60158472"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Van Hung Nguyen","raw_affiliation_strings":["VHN Consulting Inc., Montreal, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VHN Consulting Inc., Montreal, QC, Canada","institution_ids":["https://openalex.org/I60158472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054329200","display_name":"Carla Vizzotti","orcid":"https://orcid.org/0000-0003-3612-7735","observed_orcids":["https://orcid.org/0000-0003-3612-7735"]},"institutions":[{"id":"https://openalex.org/I4210109203","display_name":"Universidad Isalud","ror":"https://ror.org/01sewfq88","country_code":"AR","type":"education","lineage":["https://openalex.org/I4210109203"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Carla Vizzotti","raw_affiliation_strings":["University Isalud, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Isalud, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210109203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070535394","display_name":"Anal\u00eda Urue\u00f1a","orcid":"https://orcid.org/0000-0001-5108-2534","observed_orcids":["https://orcid.org/0000-0001-5108-2534"]},"institutions":[{"id":"https://openalex.org/I4210109203","display_name":"Universidad Isalud","ror":"https://ror.org/01sewfq88","country_code":"AR","type":"education","lineage":["https://openalex.org/I4210109203"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Analia Uruena","raw_affiliation_strings":["University Isalud, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Isalud, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210109203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011738603","display_name":"Norberto Giglio","orcid":"https://orcid.org/0000-0002-4388-8148","observed_orcids":["https://orcid.org/0000-0002-4388-8148"]},"institutions":[{"id":"https://openalex.org/I4210166344","display_name":"Hospital General de Ni\u00f1os Ricardo Gutierrez","ror":"https://ror.org/05te51w08","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210166344"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Norberto Giglio","raw_affiliation_strings":["Ricardo Gutierrez Children's Hospital, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ricardo Gutierrez Children's Hospital, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210166344"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011589923","display_name":"Cecilia Magneres","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecilia Magneres","raw_affiliation_strings":["Seqirus S.A., Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seqirus S.A., Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Heather Richmond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129217","display_name":"Seqirus (United States)","ror":"https://ror.org/03k879d12","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129217"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heather Richmond","raw_affiliation_strings":["Seqirus USA Inc., Summit, NJ, USA. Electronic address: heather.richmond@seqirus.com","Seqirus USA Inc., Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seqirus USA Inc., Summit, NJ, USA. Electronic address: heather.richmond@seqirus.com","institution_ids":["https://openalex.org/I4210129217"]},{"raw_affiliation_string":"Seqirus USA Inc., Summit, NJ, USA","institution_ids":["https://openalex.org/I4210129217"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210129217"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":{"value":3620,"currency":"USD","value_usd":3620},"fwci":1.4046,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.79954321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"38","issue":"20","first_page":"3682","last_page":"3689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trivalent-influenza-vaccine","display_name":"trivalent influenza vaccine","score":0.9319999814033508},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9629999995231628},{"id":"https://openalex.org/keywords/influenza-vaccination","display_name":"influenza vaccination","score":0.6010000109672546},{"id":"https://openalex.org/keywords/immunosenescence","display_name":"immunosenescence","score":0.8349999785423279},{"id":"https://openalex.org/keywords/influenza-mortality","display_name":"influenza mortality","score":0.39399999380111694},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9760000109672546},{"id":"https://openalex.org/keywords/vaccine-efficacy","display_name":"vaccine efficacy","score":0.4880000054836273},{"id":"https://openalex.org/keywords/argentina","display_name":"Argentina","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.5092116594314575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4945532977581024},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.42061495780944824},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.37610384821891785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32002347707748413},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.3017977476119995}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001118","descriptor_name":"Argentina","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011136","descriptor_name":"Polysorbates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013185","descriptor_name":"Squalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.vaccine.2020.02.081","doi":"https://doi.org/10.1016/j.vaccine.2020.02.081","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2020.02.081","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X2030325X/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},{"id":"pmid:32249017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32249017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.vaccine.2020.02.081","doi":"https://doi.org/10.1016/j.vaccine.2020.02.081","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2020.02.081","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X2030325X/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332036","display_name":"Seqirus","ror":"https://ror.org/03qptmm33"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3014222695.pdf","grobid_xml":"https://content.openalex.org/works/W3014222695.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W430093909","https://openalex.org/W1804248120","https://openalex.org/W1973905472","https://openalex.org/W1975597297","https://openalex.org/W1977461039","https://openalex.org/W1982855609","https://openalex.org/W1992431343","https://openalex.org/W1996493196","https://openalex.org/W2001187841","https://openalex.org/W2006921474","https://openalex.org/W2026355616","https://openalex.org/W2029292325","https://openalex.org/W2048092342","https://openalex.org/W2049703355","https://openalex.org/W2089235229","https://openalex.org/W2095069717","https://openalex.org/W2098832466","https://openalex.org/W2109801797","https://openalex.org/W2114263856","https://openalex.org/W2118705380","https://openalex.org/W2128621619","https://openalex.org/W2138915100","https://openalex.org/W2144873061","https://openalex.org/W2156580403","https://openalex.org/W2156981810","https://openalex.org/W2161772515","https://openalex.org/W2318021350","https://openalex.org/W2479127669","https://openalex.org/W2566538631","https://openalex.org/W2771874921","https://openalex.org/W2774555313","https://openalex.org/W2781211778","https://openalex.org/W2802586033","https://openalex.org/W2802620527","https://openalex.org/W2803559194","https://openalex.org/W2804447836","https://openalex.org/W2891086406","https://openalex.org/W2921919124","https://openalex.org/W3008331518","https://openalex.org/W3208081914","https://openalex.org/W6638303818","https://openalex.org/W6751583749"],"related_works":["https://openalex.org/W2903546056","https://openalex.org/W7133127706","https://openalex.org/W7166130642","https://openalex.org/W4404438130","https://openalex.org/W2922221881","https://openalex.org/W7152375458","https://openalex.org/W2026355616","https://openalex.org/W3143655730","https://openalex.org/W2794146353","https://openalex.org/W4378516755"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Influenza":[1],"surveillance":[2],"in":[3,25,54,68,83,89,124,137,187,239],"Argentina":[4,90,159,240],"reported":[5],"influenza-like":[6],"illness":[7],"at":[8],"a":[9,13,19,40,60,225],"rate":[10,15,21],"of":[11,16,22,34,42,49,76,118,135,230,254,259],"3500/100,000,":[12],"hospitalization":[14],"15.5/100,000,":[17],"and":[18,44,132,152,191,244,257],"death":[20],"0.32/100,000":[23],"annually":[24],"adults":[26,84],"aged":[27,85],"over":[28,86],"65":[29,87],"years.":[30],"The":[31,128,145,199,220],"high":[32],"burden":[33,256],"disease":[35,255],"may":[36],"be":[37],"due":[38],"to":[39,114,122,183,247],"combination":[41],"immunosenescence":[43],"the":[45,74,93,101,116,142,209,248,252],"suboptimal":[46],"clinical":[47,61],"effectiveness":[48],"conventional,":[50],"non-adjuvanted":[51,94],"influenza":[52,66,80,96,139,237],"vaccines":[53,67],"this":[55,69],"age":[56],"group.":[57],"There":[58],"is":[59,241],"need":[62],"for":[63],"more":[64],"effective":[65],"population.":[70],"This":[71],"study":[72],"evaluated":[73],"cost-effectiveness":[75,110,117,201],"an":[77,235],"MF59\u00ae-adjuvanted":[78],"trivalent":[79,95],"vaccine":[81,97,238],"(aTIV)":[82],"years":[88,196],"compared":[91,130],"with":[92],"(TIV)":[98],"used":[99],"under":[100],"current":[102],"national":[103],"vaccination":[104,136],"policy.":[105],"METHODS:":[106],"A":[107],"decision":[108],"tree":[109],"model":[111,129],"was":[112,165,205],"developed":[113],"estimate":[115],"switching":[119],"from":[120,141,158,173,181,208],"TIV":[121,182,250],"aTIV":[123,184,216],"Argentinian":[125],"older":[126],"adults.":[127],"cost":[131],"health":[133],"benefits":[134],"one":[138],"season":[140],"payer":[143,210],"perspective.":[144,211],"main":[146],"predictions":[147],"included":[148],"survival,":[149,151],"quality-adjusted":[150,194],"costs.":[153],"Model":[154],"inputs":[155],"were":[156,171],"sourced":[157],"or":[160],"internationally":[161],"where":[162],"local":[163],"data":[164],"considered":[166],"inaccurate.":[167],"Vaccine":[168],"efficacy":[169],"assumptions":[170],"extracted":[172],"recently":[174],"published,":[175],"peer-reviewed":[176],"scientific":[177],"literature.":[178],"RESULTS:":[179],"Switching":[180],"would":[185],"result":[186],"170":[188],"deaths":[189],"averted":[190],"1310":[192],"incremental":[193,200],"life":[195],"(QALYs)":[197],"gained.":[198],"ratio":[202],"per":[203,228],"QALY":[204,229],"US":[206,231],"$2660.59":[207],"In":[212],"all":[213],"sensitivity":[214,222],"analyses,":[215],"remained":[217],"highly":[218],"cost-effective.":[219],"probabilistic":[221],"analyses":[223],"showed":[224],"95%":[226],"CI":[227],"$113.74-7721.67.":[232],"CONCLUSION:":[233],"Introducing":[234],"adjuvanted":[236],"potentially":[242],"beneficial":[243],"cost-effective":[245],"relative":[246],"currently-used":[249],"through":[251],"reduction":[253],"utilization":[258],"healthcare":[260],"resources.":[261]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-04-10T00:00:00"}